Report updated Apr 30, 2026
Lipid Manager
For healthcare professionals and clinicians involved in cardiovascular risk management.
Overview · Full Intel report in progress
Lipid Manager is an established medical app that is completely free. With a 5.0/5 rating from 2 reviews, it shows polarized user reception.
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Calculates pretreatment ASCVD risk to determine the appropriateness of initiating statin therapy.
Assesses patient response to statins and provides guidance on subsequent therapy considerations.
Evaluates patients for potential statin intolerance and suggests clinical next steps.
Offers consensus-based recommendations for lifestyle and pharmacological management of persistent hypertriglyceridemia.
How much does it cost?
Who Built It?
American College of Cardiology
Providing cardiovascular clinicians with evidence-based decision support tools and professional educational resources. Standardizing cardiac care through mobile-accessible guidelines and risk modeling.
Portfolio
13
Apps
What other apps does American College of Cardiology make?
Explore the full American College of Cardiology report
Portfolio breakdown, audience, momentum, and every app published by American College of Cardiology.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for Lipid Manager?
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
29 active rankings tracked — 30-day window
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for Lipid Manager
Key Takeaways
This app serves as a specialized clinical reference tool for managing lipid-related cardiovascular risk through evidence-based decision support.
Where Is It Heading?
Trend analysis
Available very soon